Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma

  • Satoshi Kawano,
  • Alexandra R. Grassian,
  • Masumi Tsuda,
  • Sarah K. Knutson,
  • Natalie M. Warholic,
  • Galina Kuznetsov,
  • Shanqin Xu,
  • Yonghong Xiao,
  • Roy M. Pollock,
  • Jesse J. Smith,
  • Kevin W. Kuntz,
  • Scott Ribich,
  • Yukinori Minoshima,
  • Junji Matsui,
  • Robert A. Copeland,
  • Shinya Tanaka,
  •  [ ... ],
  • Heike Keilhack
  • [ view all ]
  • [ view less ]
  • Article
  • Metrics
  • Comments
  • Media Coverage

The middle initial for two authors, Jesse Smith and Kevin Kuntz, are incorrect. Their names should read Jesse J. Smith and Kevin W. Kuntz respectively.

Reference

  1. 1. Kawano S, Grassian AR, Tsuda M, Knutson SK, Warholic NM, Kuznetsov G, et al. (2016) Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma. PLoS ONE 11(7): e0158888. pmid:27391784

Citation: Kawano S, Grassian AR, Tsuda M, Knutson SK, Warholic NM, Kuznetsov G, et al. (2017) Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma. PLoS ONE 12(1): e0170539. https://doi.org/10.1371/journal.pone.0170539

Published: January 13, 2017

Copyright: © 2017 Kawano et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.